Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report

We previously published in the Journal of Thoracic Oncology the case of a patient with EGFR and MET-driven lung cancer and extracranial response to capmatinib and osimertinib. Here, we report on a second patient treated with the same combination, revealing complete and durable intracranial response....

Full description

Bibliographic Details
Main Authors: Oliver Gautschi, MD, Joachim Diebold, MD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:JTO Clinical and Research Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321000217
_version_ 1819292748395577344
author Oliver Gautschi, MD
Joachim Diebold, MD
author_facet Oliver Gautschi, MD
Joachim Diebold, MD
author_sort Oliver Gautschi, MD
collection DOAJ
description We previously published in the Journal of Thoracic Oncology the case of a patient with EGFR and MET-driven lung cancer and extracranial response to capmatinib and osimertinib. Here, we report on a second patient treated with the same combination, revealing complete and durable intracranial response. Adding capmatinib to osimertinib seems to be an effective salvage therapy for patients with EGFR-mutant lung cancer and acquired MET amplification.
first_indexed 2024-12-24T03:59:28Z
format Article
id doaj.art-e280c49bd11e4b0c9121680ef34768c7
institution Directory Open Access Journal
issn 2666-3643
language English
last_indexed 2024-12-24T03:59:28Z
publishDate 2021-04-01
publisher Elsevier
record_format Article
series JTO Clinical and Research Reports
spelling doaj.art-e280c49bd11e4b0c9121680ef34768c72022-12-21T17:16:22ZengElsevierJTO Clinical and Research Reports2666-36432021-04-0124100162Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case ReportOliver Gautschi, MD0Joachim Diebold, MD1Corresponding author. Address for correspondence: Oliver Gautschi, MD, Department of Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.; Cantonal Hospital Lucerne, Cancer Center, Lucerne, SwitzerlandCantonal Hospital Lucerne, Cancer Center, Lucerne, SwitzerlandWe previously published in the Journal of Thoracic Oncology the case of a patient with EGFR and MET-driven lung cancer and extracranial response to capmatinib and osimertinib. Here, we report on a second patient treated with the same combination, revealing complete and durable intracranial response. Adding capmatinib to osimertinib seems to be an effective salvage therapy for patients with EGFR-mutant lung cancer and acquired MET amplification.http://www.sciencedirect.com/science/article/pii/S2666364321000217Lung cancerTargeted therapyCapmatinibOsimertinibCase report
spellingShingle Oliver Gautschi, MD
Joachim Diebold, MD
Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
JTO Clinical and Research Reports
Lung cancer
Targeted therapy
Capmatinib
Osimertinib
Case report
title Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
title_full Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
title_fullStr Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
title_full_unstemmed Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
title_short Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report
title_sort intracranial activity of osimertinib plus capmatinib in a patient with egfr and met driven lung cancer case report
topic Lung cancer
Targeted therapy
Capmatinib
Osimertinib
Case report
url http://www.sciencedirect.com/science/article/pii/S2666364321000217
work_keys_str_mv AT olivergautschimd intracranialactivityofosimertinibpluscapmatinibinapatientwithegfrandmetdrivenlungcancercasereport
AT joachimdieboldmd intracranialactivityofosimertinibpluscapmatinibinapatientwithegfrandmetdrivenlungcancercasereport